{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:48:32Z","timestamp":1768513712311,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neonates with congenital CMV (cCMV) with hearing loss at birth have improved hearing and developmental outcomes when treatment is started within the first 4\u00a0weeks of life. This report retrospectively evaluates the performance of a targeted diagnostic pathway for \u2018otherwise well\u2019 neonates who fail their newborn hearing screen. Approximately 10% of \u2018otherwise well\u2019 neonates who failed their newborn hearing screen and were subsequently diagnosed with sensorineural hearing loss were identified as having cCMV, highlighting the pathway\u2019s diagnostic utility. Our findings do, however, identify a missed subgroup\u2014infants with complex medical needs requiring prolonged neonatal hospital stays\u2014who are often referred for audiology assessment too late for timely cCMV testing. These findings support the need to optimise early referral pathways to ensure that all at-risk neonates are offered diagnostic cCMV testing within the recommended time frame.<\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Treatment of symptomatic cCMV infection in neonates started timely before 4\u00a0weeks of life, improves hearing and developmental outcomes<\/jats:italic>\n                              .\u2022\n                              <jats:italic>cCMV screening for all neonates is not available in all countries<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>This report demonstrates the diagnostic utility of a regional pathway embedded within the UK Newborn Hearing Screening Programme for identifying \u2018otherwise well\u2019 neonates with cCMV-associated hearing loss timely, allowing start of treatment within the first 4\u00a0weeks of life<\/jats:italic>\n                              .\u2022\n                              <jats:italic>Alternative strategies are required for premature and unwell hospitalised neonates<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-025-06612-9","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:51:24Z","timestamp":1762829484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted congenital cytomegalovirus screening as part of the newborn hearing screening programme in Northeast England"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-3949","authenticated-orcid":false,"given":"Alexander J.","family":"Hagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleri J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7181-4608","authenticated-orcid":false,"given":"Steven","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-2843","authenticated-orcid":false,"given":"Janet","family":"Berrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3527","authenticated-orcid":false,"given":"Marieke","family":"Emonts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"6612_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.20736","volume":"4","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Hehnly C, Birungi P, Roach MA, Spady J, Fronterre C et al (2021) Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis. JAMA Netw Open 4:e2120736. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.20736","journal-title":"JAMA Netw Open"},{"key":"6612_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","volume":"164","author":"AM Dreher","year":"2014","unstructured":"Dreher AM, Arora N, Fowler KB, Novak Z, Britt WJ, Boppana SB et al (2014) Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr 164:855\u2013859. https:\/\/doi.org\/10.1016\/j.jpeds.2013.12.007","journal-title":"J Pediatr"},{"key":"6612_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17:355\u2013363. https:\/\/doi.org\/10.1002\/rmv.544","journal-title":"Rev Med Virol"},{"key":"6612_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1542\/peds.2014-1173","volume":"134","author":"J Goderis","year":"2014","unstructured":"Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I (2014) Hearing loss and congenital CMV infection: a systematic review. Pediatrics 134:972\u2013982. https:\/\/doi.org\/10.1542\/peds.2014-1173","journal-title":"Pediatrics"},{"key":"6612_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpeds.2018.02.028","volume":"199","author":"Y Pasternak","year":"2018","unstructured":"Pasternak Y, Ziv L, Attias J, Amir J, Bilavsky E (2018) Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss. J Pediatr 199:166\u2013170. https:\/\/doi.org\/10.1016\/j.jpeds.2018.02.028","journal-title":"J Pediatr"},{"key":"6612_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1938","volume":"27","author":"AW Bartlett","year":"2017","unstructured":"Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P (2017) Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review. Rev Med Virol 27:e1938. https:\/\/doi.org\/10.1002\/rmv.1938","journal-title":"Rev Med Virol"},{"key":"6612_CR7","doi-asserted-by":"publisher","unstructured":"Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N et al (2024) Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg Health Eur 40.  https:\/\/doi.org\/10.1016\/j.lanepe.2024.100892 (Elsevier [cited 2025 July 31])","DOI":"10.1016\/j.lanepe.2024.100892"},{"key":"6612_CR8","doi-asserted-by":"publisher","first-page":"F230","DOI":"10.1136\/archdischild-2013-305276","volume":"99","author":"EJ Williams","year":"2014","unstructured":"Williams EJ, Kadambari S, Berrington JE, Luck S, Atkinson C, Walter S et al (2014) Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed 99:F230-236. https:\/\/doi.org\/10.1136\/archdischild-2013-305276","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6612_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJMoa1404599","volume":"372","author":"DW Kimberlin","year":"2015","unstructured":"Kimberlin DW, Jester PM, S\u00e1nchez PJ, Ahmed A, Arav-Boger R, Michaels MG et al (2015) Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372:933\u2013943. https:\/\/doi.org\/10.1056\/NEJMoa1404599","journal-title":"N Engl J Med"},{"key":"6612_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00431-019-03379-8","volume":"178","author":"EA van Beeck Calkoen","year":"2019","unstructured":"van Beeck Calkoen EA, Engel MSD, van de Kamp JM, Yntema HG, Goverts ST, Mulder MF et al (2019) The etiological evaluation of sensorineural hearing loss in children. Eur J Pediatr 178:1195\u20131205. https:\/\/doi.org\/10.1007\/s00431-019-03379-8","journal-title":"Eur J Pediatr"},{"key":"6612_CR11","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1186\/s12889-022-13971-7","volume":"22","author":"K Fowler","year":"2022","unstructured":"Fowler K, Mucha J, Neumann M, Lewandowski W, Kaczanowska M, Grys M et al (2022) A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health 22:1659. https:\/\/doi.org\/10.1186\/s12889-022-13971-7","journal-title":"BMC Public Health"},{"key":"6612_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","volume":"11","author":"SB Boppana","year":"1992","unstructured":"Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93\u201399. https:\/\/doi.org\/10.1097\/00006454-199202000-00007","journal-title":"Pediatr Infect Dis J"},{"key":"6612_CR13","unstructured":"Newborn hearing screening programme: standards [Internet]. GOV.UK. 2025 [cited 2025 Oct 6]. https:\/\/www.gov.uk\/government\/publications\/newborn-hearing-screening-programme-quality-standards. Accessed 6 Oct 2025"},{"key":"6612_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.113934","volume":"268","author":"DW Kimberlin","year":"2024","unstructured":"Kimberlin DW, Aban I, Peri K, Nishikawa JK, Bernatoniene J, Emonts M et al (2024) Oral valganciclovir initiated beyond 1 month of age as treatment of sensorineural hearing loss caused by congenital cytomegalovirus infection: a randomized clinical trial. J Pediatr 268:113934. https:\/\/doi.org\/10.1016\/j.jpeds.2024.113934","journal-title":"J Pediatr"},{"key":"6612_CR15","doi-asserted-by":"publisher","first-page":"113945","DOI":"10.1016\/j.jpeds.2024.113945","volume":"268","author":"PK Chung","year":"2024","unstructured":"Chung PK, Schornagel FAJ, Soede W, van Zwet EW, Kroes ACM, Oudesluys-Murphy AM et al (2024) Valganciclovir in infants with hearing loss and clinically inapparent congenital cytomegalovirus infection: a nonrandomized controlled trial. J Pediatr 268:113945. https:\/\/doi.org\/10.1016\/j.jpeds.2024.113945","journal-title":"J Pediatr"},{"key":"6612_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12879-020-4941-z","volume":"20","author":"L Pellegrinelli","year":"2020","unstructured":"Pellegrinelli L, Alberti L, Pariani E, Barbi M, Binda S (2020) Diagnosing congenital cytomegalovirus infection: don\u2019t get rid of dried blood spots. BMC Infect Dis 20:217. https:\/\/doi.org\/10.1186\/s12879-020-4941-z","journal-title":"BMC Infect Dis"},{"key":"6612_CR17","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.1007\/s10545-010-9125-3","volume":"33","author":"SC Dollard","year":"2010","unstructured":"Dollard SC, Schleiss MR, Grosse SD (2010) Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus. J Inherit Metab Dis 33:S249-254. https:\/\/doi.org\/10.1007\/s10545-010-9125-3","journal-title":"J Inherit Metab Dis"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06612-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:43:50Z","timestamp":1768459430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06612-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6612"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06612-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"747"}}